QI
AVNS

Quotient Investors’s Avanos Medical AVNS Stock Holding History

Quotient Investors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$203K Buy
+4,500
New +$192K 0.14% 132

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Quotient Investors's AVNS Position: Q3 2017 in Review

Quotient Investors opened a new position in Avanos Medical (AVNS) in Q3 2017: 4,500 shares worth $203K. The stake represents 0.14% of the portfolio and ranks #132 among its holdings.

318 funds tracked by Wall St. Rank hold AVNS as of Q3 2017.

  • Quotient Investors held 4,500 shares of Avanos Medical worth $203K as of Q3 2017.
  • Avanos Medical was a new Quotient Investors position in Q3 2017.
  • Avanos Medical made up 0.14% of Quotient Investors's portfolio in Q3 2017, its #132 holding.
  • 318 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2017.

Based on Quotient Investors's 13F filing for Q3 2017, filed 18 Oct 2017.